Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy.
about
Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients.The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer.Toxicity after post-prostatectomy image-guided intensity-modulated radiotherapy using Australian guidelines.Is there a benefit to locally consolidative therapy for oligometastatic non-small cell lung cancer?Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends.Improving postoperative radiotherapy following radical prostatectomy.Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after 68Ga-PSMA-PET imaging.Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy.Hallmarks in prostate cancer imaging with Ga68-PSMA-11-PET/CT with reference to detection limits and quantitative properties.PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives.
P2860
Q38613594-F0A639B0-8900-4BA9-8EDF-BC5567726C21Q38720852-1E2E2DEC-EA61-4283-8E00-02FF8EBED4A5Q38721392-94BF6099-74C2-444D-8D7C-1B0086B76605Q42314906-B3E07FD4-87C8-4BD5-BA92-148599BDA823Q43578455-AA807F41-9509-4246-A11D-1B0E8BD89240Q47269407-29C2EDC1-42E4-4E9A-ACDB-24E3D3B6198AQ47978964-BA7CD257-3C27-4638-AAC2-5FBCD0EB9785Q50034009-4B061963-99A4-4FF4-9263-16575C6C9D50Q50083626-E9078180-BB74-4F6B-ADE2-639369DA29E6Q51840218-1FB121B5-039F-4A66-B1D3-DD5B60C153ADQ55118858-B0EA66BC-6DBB-4715-9D01-99871B1DAA47Q55185843-02544184-A7D0-4F47-BD81-65EAFD4240C9Q55399763-DB9F5C24-63D8-4A03-B071-B2CB9C691D71
P2860
Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Impact of 68Ga-PSMA PET/CT on ...... l relapse after prostatectomy.
@en
type
label
Impact of 68Ga-PSMA PET/CT on ...... l relapse after prostatectomy.
@en
prefLabel
Impact of 68Ga-PSMA PET/CT on ...... l relapse after prostatectomy.
@en
P2093
P2860
P1433
P1476
Impact of 68Ga-PSMA PET/CT on ...... l relapse after prostatectomy.
@en
P2093
Andreas Schirbel
Axel Becker
Christian Kestler
Christina Bluemel
Daniel Vergho
Fraenze Linke
Hans-Juergen Wester
Iva Simunovic
Ken Herrmann
Matthias Eiber
P2860
P2888
P356
10.1186/S13550-016-0233-4
P577
2016-10-26T00:00:00Z
P6179
1016377175